Get the tools used by (smart)2 investors.
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Depreciation & Amortization

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

-
Price
–
Fair Value
–
Upside
- - -
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on 's Depreciation & Amortization:

Jan 2017Dec 2018Jan 2021Jan 2023Dec 20244 B6 B8 B
Performance Summary
  • Johnson & Johnson's latest twelve months depreciation & amortization is 7.339 billion
  • Johnson & Johnson's depreciation & amortization for fiscal years ending January 2021 to 2024 averaged 6.931 billion.
  • Johnson & Johnson's operated at median depreciation & amortization of 7.103 billion from fiscal years ending January 2021 to 2024.
  • Looking back at the last 5 years, Johnson & Johnson's depreciation & amortization peaked in December 2024 at 7.339 billion.
  • Johnson & Johnson's depreciation & amortization hit its 5-year low in January 2023 of 6.329 billion.
  • Johnson & Johnson's depreciation & amortization decreased in 2022 (6.651 billion, -8.0%) and 2023 (6.329 billion, -4.8%) and increased in 2021 (7.231 billion, +3.2%), 2023 (7.103 billion, +12.2%), and 2024 (7.339 billion, +3.3%).

How does J&J's Depreciation & Amortization benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Johnson & Johnson because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

J&J Depreciation & Amortization Benchmarks
NameTickerDepreciation & Amortization
Vyne Therapeutics IncNASDAQCM:VYNE4 K
Talphera IncNASDAQGM:TLPH72 K
NovaBay Pharmaceuticals IncNYSEAM:NBY196 K
Nutriband IncNASDAQCM:NTRB281.539 K
HealthcareSECTOR:HLTH.US1.43 M
ANI Pharmaceuticals IncNASDAQGM:ANIP67.731 M
Eli Lilly and CompanyNYSE:LLY1.767 B
Viatris IncNASDAQGS:VTRS2.708 B
Merck & Company IncNYSE:MRK4.245 B
Novartis AG ADRNYSE:NVS4.342 B
Johnson & JohnsonNYSE:JNJ7.339 B
Bristol-Myers Squibb CompanyNYSE:BMY9.575 B

Metric Usage: Depreciation & Amortization

Hide this widget
da
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Depreciation & Amortization in the financials category include:

  • Net Current Asset Value (NCAV) - A calculation inspired by Benjamin Graham. Net Current Asset Value is calculated as current assets minus total liabilities.
  • Unearned Revenue Non Current - Revenue collected or promised for which the reporting company still has to provide goods or services over 12 months into the future.
  • Assets on Oper. Lease, Accum. Depr. - This item represents the closing i.e. year-end accumulated balances of amounts provided as depreciation over the life of the assets given by the company on operating leases to others, till the end of the current year.
  • Other Investing Activities - This item represents all other investing cash flows not included in any specific data item.
View Full List

Search for metric or datapoint

Depreciation & Amortization

The sum of depreciation and amortization expenses.

Definition of Depreciation & Amortization

Hide this widget
The sum of depreciation and amortization expenses.

Sector Benchmark Analysis

All rights reserved. Terms Of Use